A key molecular mechanism drives the growth of liver cell cancer while simultaneously suppressing the body’s immune response to the tumor. This has been published in the journal Nature by a team led by researchers from the German Cancer Research Center (DKFZ), the University Hospital of Tübingen, and the Sanford Burnham Prebys Medical Discovery Institute in La Jolla, California. However, the results also show that this very mechanism could help identify patients who respond particularly well to immunotherapy in the future, thus opening up new therapeutic approaches.
This article was originally published on MedicalXpress.com
